insulin glargine, an analog of human insulin produced by recombinant DNA technology, differing from human insulin in that the asparagine at position A21 is replaced by glycine and two arginines are added to the C-terminus of the B-chain. It is administered subcutaneously for once-daily insulin replacement therapy.
